Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Race Oncology Ltd. ( (AU:RAC) ).
Race Oncology Ltd has announced the quotation of 243,710 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of November 20, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its ongoing cancer research and development initiatives, potentially strengthening its market position and offering new opportunities for stakeholders.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies. The company is primarily engaged in researching and bringing to market innovative treatments for various types of cancer, with a strong emphasis on improving patient outcomes.
Average Trading Volume: 536,785
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$611.2M
See more data about RAC stock on TipRanks’ Stock Analysis page.